OAM
MRVI icon

Ophir Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Ophir Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1M Buy
+4,826,698
New +$20.8M 2.48% 20
2021
Q1 		– Sell
-494,971
Closed -$13.9M – 42
2020
Q4 		$13.9M Buy
+494,971
New +$13.8M 4.52% 7

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ophir Asset Management's MRVI Position: Q2 2026 in Review

Ophir Asset Management opened a new position in Maravai LifeSciences (MRVI) in Q2 2026: 4,826,698 shares worth $30.1M. The stake represents 2.48% of the portfolio and ranks #20 among its holdings. This is a return to the name: Ophir Asset Management previously reported a position in MRVI as recently as Q4 2020.

Ophir Asset Management first reported a position in MRVI in Q4 2020 and has held it in 2 quarters since. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Ophir Asset Management held 4,826,698 shares of Maravai LifeSciences worth $30.1M as of Q2 2026.
  • Maravai LifeSciences was a new Ophir Asset Management position in Q2 2026.
  • Maravai LifeSciences made up 2.48% of Ophir Asset Management's portfolio in Q2 2026, its #20 holding.
  • Ophir Asset Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 2 quarters since.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Ophir Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.